BCM
CYTR

Brookstone Capital Management’s CytRx Corp CYTR Stock Holding History

Brookstone Capital Management’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-11
Closed – – 1124
2015
Q3 		$0 Hold
11
– – ﹤0.01% 2263
2015
Q2 		$0 Buy
+11
New +$275 ﹤0.01% 2219

Other funds holding CYTR

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Brookstone Capital Management's CYTR Position: Q4 2015 in Review

Brookstone Capital Management sold out of CytRx Corp (CYTR) in Q4 2015, closing a stake of 11 shares.

Brookstone Capital Management first reported a position in CYTR in Q2 2015 and held it in 2 quarters. The position peaked at $0 in Q3 2015. 65 funds tracked by Wall St. Rank hold CYTR as of Q4 2015.

  • Brookstone Capital Management reported no remaining CytRx Corp position as of Q4 2015 after selling out during the quarter.
  • Brookstone Capital Management sold 11 CytRx Corp shares in Q4 2015.
  • Brookstone Capital Management first reported a position in CytRx Corp in Q2 2015 and held it in 2 quarters.
  • Brookstone Capital Management's CytRx Corp position peaked at $0 in Q3 2015.
  • 65 funds tracked by Wall St. Rank held CytRx Corp as of Q4 2015.

Based on Brookstone Capital Management's 13F filing for Q4 2015, filed 14 Jan 2016.